Related Experiment Video

Updated: Oct 25, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Difference in Prognosis between Continuation and Discontinuation of A 5-Month Cardiac Rehabilitation Program in

Hidetaka Morita1, Yasunori Suematsu1, Kai Morita1

  • 1Department of Cardiology, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka 814-0180, Japan.

Journal of Clinical Medicine
|August 7, 2021
PubMed

Insights

Continuing cardiac rehabilitation (CR) for heart failure (HF) patients, including those with preserved ejection fraction (HFpEF), significantly reduces death and hospital admissions. This highlights the importance of sustained CR programs for better HF outcomes.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Rehabilitation Science

Background:

  • Cardiac rehabilitation (CR) is essential for heart failure (HF) patient care.
  • Evaluating CR's impact on HF with preserved ejection fraction (HFpEF) versus non-HFpEF is crucial.
  • Understanding the benefits of continuing versus discontinuing CR programs is key.

Purpose of the Study:

  • To compare clinical outcomes in HFpEF patients versus non-HFpEF patients undergoing a 5-month CR program.
  • To assess the impact of continuing vs. discontinuing CR on patient outcomes.
  • To determine if CR continuation benefits both HFpEF and non-HFpEF populations.

Main Methods:

  • 173 outpatients with HF were enrolled in a 5-month CR program.
  • Patients were categorized into HFpEF (n=84) and non-HFpEF (n=89) groups.
  • Outcomes were compared between patients who continued and discontinued the CR program within each group.

Main Results:

  • No significant baseline differences between continued and discontinued groups, except for diabetes in non-HFpEF.
  • All-cause death and hospital admissions were significantly lower in the continued CR groups (HFpEF and non-HFpEF).
  • CR program continuation was independently associated with reduced death and hospital admissions.

Conclusions:

  • Continuation of a 5-month CR program prevents all-cause death and hospital admissions.
  • This benefit was observed in both HFpEF and non-HFpEF patient groups.
  • Sustained CR participation is vital for improving outcomes in diverse HF populations.
Abstract

Keywords:
cardiac rehabilitation programcontinued groupdiscontinued grouppreserved ejection fraction

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
73
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
112
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
165
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
63
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
55